STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”), has signed a multi-year license agreement (the “Agreement”) with WestPoint Home, LLC – a premier U.S. textile manufacturing company – to provide CertainT® platform services for their hospitality bedding and textile goods. Under the terms of the Agreement, WestPoint Home has been granted the exclusive right to use Applied DNA’s CertainT platform for its collection of blended duvets, towels, sheets, pillow cases, bed skirts, shams, and decorative pillow products sold for hospitality in Canada, Mexico and the US. Also under the Agreement, WestPoint Home has been granted non-exclusive global CertainT platform rights for various hospitality opportunities. WestPoint Home will use Applied DNA’s CertainT platform from start to finish – assuring that any of its hospitality textile products using PET and recycled rPET contain the original source raw materials.
“Our partnership with Applied DNA adds to our already extensive assortment of environmentally sustainable products and processes,” commented Normand Savaria, President and CEO of WestPoint Home. “As leaders in supply chain transparency and accuracy we are excited to be adding the CertainT platform and technology to our product offerings.”
As part of the platform, Applied DNA’s molecular tags are embedded into the source materials that create polyester (PET) and recycled polyester (rPET) fiber – with no impact on fiber’s performance or quality. CertainT-tagged textiles can be forensically authenticated by detecting this molecular tag in both PET and rPET fiber – ensuring its authenticity and origin.
“The CertainT platform helps WestPoint Home produce innovative products utilizing an efficient and trusted traceability system with a fair return,” said Dr. James Hayward, president and CEO of Applied DNA. “Differentiating their brand throughout the hospitality industry through use of our CertainT trademark will confirm to the wide variety of clientele within this special market that the products comply with our supply chain platform and are verifiably made from recycled fibers.”
About WestPoint Home
Since 1813 WestPoint Home has been a leader in the design, manufacturing and distribution of textiles for both consumer and commercial end uses.
WestPoint Hospitality provides their commercial clients with a curated assortment of bed and bath products that are engineered to ensure the highest levels of operational efficiency and guest satisfaction. WestPoint Hospitality’s line of bed and bath linens include sheets, towels, decorative bedding, blankets and filled utility products.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics. The Company makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
The proprietary DNA-based CertainT® platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.